Home » Topics » Disease categories and therapies » Infection

Infection
RSS

BE-54476, a new antibacterial substance produced by a species of Streptomyces

May 30, 2000

Takeda describes new injectable antifungal agents

May 30, 2000

Roche withdraws application to CPMP for Tamiflu; resubmission planned in near future

May 29, 2000

Antibacterial agents with naphthyridine structure under study at SmithKline Beecham

May 26, 2000

Roche files for new Tamiflu indication with FDA

May 26, 2000

Recent patent covers new quinolone antibacterial agents synthesized at SB

May 25, 2000

New quinolones useful as antiinfective monotherapy or in combination

May 24, 2000

Cubist seeks to expand daptomycin companion study; positive results presented in endocarditis model

May 24, 2000

Novel antibacterial agents from Scriptgen selectively inhibit bacterial RNA polymerase

May 23, 2000

Immtech to establish research consortium for leishmaniasis therapy

May 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...